MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Comparison of Dementia Patients With and Without Parkinson’s Disease Before Dementia-related Psychosis Occurs: An Administrative Claims Data Analysis

    A. Shim, B. Skoog, V. Abler, N. Rashid, R. Halpern, E. Koep, M. Frazer (San Diego, CA, USA)

    Objective: Describe and compare patients with evidence of dementia-related psychosis diagnosed with Parkinson’s disease with dementia (PDD) versus patients with dementia but no Parkinson’s disease…
  • 2019 International Congress

    Incidental iron deposition in basal ganglia: does the pattern matter? Fifteen years’ experience in a tertiary care center.

    á. Beltrán Corbellini, P. Pérez Torre, A. Alonso Cánovas, F. Rodríguez Jorge, JL. Chico García, P. Parra Díaz, E. Natera Villalba, A. Gómez López, S. Fanjul Arbos, JL. López Sendón, JC. Martínez Castrillo, I. Parées Moreno (Madrid, Spain)

    Objective: We describe our series of patients with iron deposition in basal ganglia (IDBG) and hypothesize differences regarding the affected nuclei in patients with movement…
  • 2019 International Congress

    Is Microelectrode Recording mandatory for Deep Brain Stimulation in Parkinson’s disease?

    J. Bajaj, M. Singh, V. Goyal, S. Girishan, K. Garg (Delhi, India)

    Objective: To find whether microelectrode recording (MER) is mandatory for deep brain stimulation (DBS) in Parkinson’s disease. Background: DBS is traditionally done using MER guidance.…
  • 2019 International Congress

    Intraoperative test stimulation of the subthalamic nucleus reduces the search space for chronic stimulation settings in Parkinson’s disease

    V. Geraedts, R. van Ham, J. Marinus, J. van Hilten, A. Mosch, C. Hoffmann, N. Vd Gaag, MF. Contarino (Leiden, Netherlands)

    Objective: To determine whether intraoperative test stimulation is indicative of postoperative stimulation results. Background: It is unknown whether intraoperative testing during awake Deep Brain Stimulation…
  • 2019 International Congress

    Strategies for Implementation of a Quality Improvement Registry for DBS in Parkinson’s Disease

    J. Jimenez-Shahed, P. D'Haese, J. Kirk, M. York, A. Berg, L. Shih, J. Schwalb, J. Mcinerney (Houston, TX, USA)

    Objective: To describe the implementation of a quality improvement (QI) patient registry for deep brain stimulation (DBS) in Parkinson's disease (PD). Background: QI projects are…
  • 2019 International Congress

    DBS in Parkinson’s disease: Experience from Egypt

    A. Mansour, Z. Fayed (Cairo, Egypt)

    Objective: To highlight our Experience in DBS for Parkinson’s in Egypt, to our knowledge we are the first team for DBS in Egypt, and so…
  • 2019 International Congress

    Surgery‐related 30-day morbidity of deep brain stimulation in a large cohort of 600 patients

    J. Runge, A. Saryyeva, C. Blahak, C. Schrader, H. Bäzner, HH. Capelle, M. Abdallat, M. Wolf, TM. Kinfe, JK. Krauss (Hannover, Germany)

    Objective: In this retrospective study we analyzed the surgery‐ and hardware‐related morbidity of deep brain stimulation within 30 days after surgery. Background: 600 functional stereotactic…
  • 2019 International Congress

    Changing for a rechargeable neurostimulator in Parkinson’s disease patients: safety and feasibility

    T. Wirth, C. Laurencin, J. Berthiller, A. Brindzeu, E. Simon, G. Polo, P. Mertens, E. Broussolle, T. Danaila, S. Thobois (Strasbourg, France)

    Objective: This study aimed to determine the feasibility and safety of the replacement of non-rechargeable implanted pulse generator (IPG) by rechargeable ones. Background: DBS of…
  • 2019 International Congress

    Single Centre Experience of PEG Feeding in Parkinson’s Disease

    H. Fairclough, H. Bashir, R. Beekman, M. Lee, E. Johns, C. Mcdonald (Gateshead, United Kingdom)

    Objective: To determine factors influencing mortality in patients who receive percutaneous endoscopic gastrostomy (PEG) in Parkinson ’s disease (PD). Background: PD is a progressive neurological…
  • 2019 International Congress

    Ipsilesional arm levitation after left hemispheric stroke: a case series

    M. Klarendic, N. Prezelj, R. Berlot, V. Zgonc, M. Kojovic (Ljubljana, Slovenia)

    Objective: We present three patients with left hemispheric stroke and spontaneous ipsilesional arm levitation (IAL), a phenomenon not hitherto described. Background: Spontaneous arm levitation (AL) is…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley